Company / Operating Income per Share
Ernexa Therapeutics Inc. Operating Income per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.58
FY2025
5-year range
-$6.48 / $0.07
FY2021-FY2025
Trend
-17.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-6.48 in FY2023 to $0.07 in FY2019.
Based on SEC 10-K filings.
-4.58 in FY2025.
Improved from $-6.48 to $-4.58 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 17.1% year-over-year.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.58 | -17.1% |
| FY2024 | -$3.91 | +39.7% |
| FY2023 | -$6.48 | -966.7% |
| FY2020 | -$0.61 | -960.2% |
| FY2019 | $0.07 | +112.7% |
| FY2018 | -$0.56 | -2156.7% |
| FY2017 | -$0.02 | +99.3% |
| FY2016 | -$3.73 | -7163.8% |
| FY2015 | -$0.05 | -260.8% |
| FY2014 | -$0.01 | +4.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026